Ying Liu
8 Papers
Ying Liu is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has co-authored 4 publications.
Chat about Author
Papers
Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia.
Troy M. Robinson,Robert L. Bowman,Sonali Persaud,Ying Liu,Rosemary Neigenfind,Qi Gao,Jingping Zhang,Linde A. Miles,Sheng F Cai,Adam Sciambi,Aaron Llanso,Christopher Famulare,Aaron Goldberg,Ahmet Dogan,Mikhail Roshal,Ross L Levine,Wenbin Xiao +16 more
TL;DR: The scMRD assay enhances MRD detection and simultaneously illuminates the clonal architecture of clonal hematopoiesis/preleukemic and leukemic cells surviving acute myeloid leukemia therapy.
23
Highly sensitive single tube B-lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy.
Qi Gao,Ying Liu,Umut Aypar,Jee-Sun Baik,Dory Londono,Xiaotian Sun,Jingping Zhang,Yanming Zhang,Mikhail Roshal +8 more
TL;DR: In this article , a single tube flow cytometry assay (14-color-16-parameters) was developed for sensitive disease detection of B-ALL MRD independent of CD19 and CD22 expression.
9
Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
Ying Liu,Andriy Derkach,Natasha Lewis,Menglei Zhu,Yanming Zhang,M. Arcila,Gilles Salles,Ahmet Dogan,Wenbin Xiao +8 more
TL;DR: In this paper, the authors propose a method to solve the problem of "not available" data: https://www.youtube.com/watch/watch?feature=youtu.
Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity
Pallavi Galera,Deepika Dilip,Andriy Derkach,Alex Chan,Yanming Zhang,Sonali Persuad,Tanmay Mishera,Ying Liu,Christopher Famulare,Qi Gao,Douglas A. Mata,Maria Arcila,Mark B. Geyer,Eytan S. Stein,Ahmet Dogan,Ross L Levine,Mikhail Roshal,Jacob L. Glass,Wenbin Xiao +18 more
TL;DR: It is demonstrated for the first time that AML-MP clinically and biologically resembles its AML counterpart without MP and differs from MPAL, supporting the recommendation to exclude these patients from the diagnosis of MPAL.
2
Quantification of Measurable Residual Disease Detection by Next Generation Sequencing-based Clonality Testing in B-cell and Plasma Cell Neoplasms.
Ying Liu,Caleb Ho,Wayne Yu,Ying Huang,Jeffrey Miller,Qi Gao,Mustafa Syed,Yuanyuan G. Ma,Meiyi Wang,Lidia Maciag,Kseniya Petrova-Drus,Menglei Zhu,Jinjuan Yao,Chad Vanderbilt,Benjamin Durham,Jamal Benhamida,Mark D. Ewalt,Ahmet Dogan,Mikhail Roshal,Khedoudja Nafa,Maria E. Arcila +20 more
TL;DR: This NGS-based MRD assay showed highly reproducible results with quantitation that correlated well with FC MRD assessment, particularly for B-cell neoplasms, and showed highly concordant MRD detection and quantitation.
1